Valued Differently

We founded MaximForte on a simple conviction: healthcare businesses are valued differently. Licenses, clinical reputation, payor mix and compliance history matter as much as earnings — sometimes more. Two companies with identical profit can sell for multiples that are years of income apart, and the difference is rarely the P&L. It's the durability of the revenue behind it. Nowhere is that clearer than in the payor line — and no payor moves the goalposts more often than Medicare. This issue is about what the shifting Medicare billing landscape means for what your company is actually worth.

Why the same dollar isn't the same dollar

When a buyer underwrites a founder-built healthcare company, the first schedule their analysts build isn't revenue growth — it's revenue composition. Commercial, Medicare fee-for-service, Medicare Advantage, Medicaid, cash-pay: each line carries its own reimbursement trajectory, its own audit exposure, and its own probability of looking different five years from now. A dollar of diversified commercial revenue and a dollar of single-program government revenue book identically in QuickBooks and are priced very differently in a sale. That is what "valued differently" means in practice: the multiple is applied not to your earnings, but to the buyer's confidence that those earnings survive the next rule cycle.

The Medicare landscape is moving — in both directions

Medicare's billing rules are rewritten every year, and the last few cycles have been unusually eventful. Four shifts matter most to owners weighing an exit:

1. Fee-schedule whiplash. Physician reimbursement fell for years in real terms — the 2025 conversion factor was cut roughly 2.8% — before Congress and CMS reversed course with an increase for 2026, introducing for the first time separate conversion factors for practices in advanced value-based models versus everyone else. Buried in the same rulebook: an "efficiency adjustment" that trims payment for many procedure-heavy services. The signal is unmistakable — fee-for-service medicine is being repriced, specialty by specialty, and value-based participation is becoming a valuation asset in its own right.

2. Medicare Advantage is now the main street. More than half of Medicare beneficiaries are enrolled in MA plans. For providers, that converts a single federal payor into a portfolio of negotiated commercial-style contracts — each with its own rates, prior-authorization regime, and termination clauses. Buyers now diligence MA contract concentration the way they diligence customer concentration in any other industry: a business where two plans control most of the volume carries risk no matter how strong the margins.

3. The audit era. Washington has moved decisively toward auditing what it pays. Risk-adjustment audits of MA plans are expanding dramatically, and that pressure flows downhill to providers through documentation demands, coding scrutiny, and clawback exposure. In diligence, a clean audit history and disciplined documentation have become priced assets; open audits, unusual coding patterns, or informal billing practices have become priced liabilities — and occasionally deal-breakers.

4. Temporary rules, permanent uncertainty. Telehealth flexibilities, hospital-at-home waivers, and a series of pandemic-era allowances have lived on short congressional extensions, sometimes lapsing and reviving within a single quarter. Revenue built on a flexibility with an expiration date is discounted accordingly — buyers model the cliff even when Congress keeps postponing it.

What buyers do with all this

Sophisticated acquirers don't take your trailing twelve months at face value; they re-underwrite it. Medicare-heavy revenue gets restated at forward rates under the newest final rule. MA revenue gets stress-tested against contract renegotiation. Revenue tied to expiring flexibilities gets haircut or excluded. Then the adjusted earnings — not the ones in your financials — get the multiple. This is why two home-health agencies, two physician groups, or two pharmacies with identical income statements can receive offers that are millions apart. One of them can show durable, diversified, well-documented revenue. The other is asking the buyer to absorb policy risk — and buyers charge for that.

The owner's checklist

None of this argues for panic, and none of it means Medicare-facing businesses can't command premium outcomes — they do, constantly. It argues for preparation. Five questions to answer while an exit is still years away:

Know your mix. What percentage of revenue comes from each payor — and from each MA plan individually? If you can't answer in one page, neither can a buyer, and uncertainty is always priced against the seller.

Map your rule exposure. Which billing codes and settings drive your margin, and what did the last two final rules do to them? A business that can narrate its own reimbursement story controls the diligence conversation.

Audit yourself first. Coding accuracy, documentation completeness, and compliance-program hygiene are now valuation line items. Findings you discover and fix are footnotes; findings a buyer discovers are discounts.

Diversify deliberately. Commercial contracts, cash-pay lines, and value-based arrangements each dilute single-payor risk. Even modest diversification, demonstrated over a couple of years, changes how the revenue base is characterized.

Paper your quality. Licenses in good standing, survey history, clinical outcomes, patient satisfaction — the "clinical reputation" half of the conviction. It lives in documents, not reputation alone, and assembling it takes months, not days.

The theme of this brief is the theme of our practice: in healthcare, value is built as much in the payor file and the compliance drawer as on the income statement. Owners who treat reimbursement policy as weather — something that happens to them — sell into whatever conditions prevail. Owners who treat it as terrain to be mapped choose their moment, and their number shows it.

Reimbursement figures reflect published CMS rulemaking through early 2026 and are simplified for readability; rules change annually and mid-year. This brief is general information, not reimbursement, legal, or tax advice — verify current rates and policies with your billing advisors.